Teleflex Inc
NYSE:TFX

Watchlist Manager
Teleflex Inc Logo
Teleflex Inc
NYSE:TFX
Watchlist
Price: 177.26 USD -0.56% Market Closed
Market Cap: 8.2B USD
Have any thoughts about
Teleflex Inc?
Write Note

Teleflex Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Teleflex Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Teleflex Inc
NYSE:TFX
Operating Income
$539.8m
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
6%
Becton Dickinson and Co
NYSE:BDX
Operating Income
$2.9B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
6%
Boston Scientific Corp
NYSE:BSX
Operating Income
$2.9B
CAGR 3-Years
20%
CAGR 5-Years
10%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
Operating Income
$4.8B
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Operating Income
$7B
CAGR 3-Years
-7%
CAGR 5-Years
10%
CAGR 10-Years
11%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Income
$2.1B
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
14%
No Stocks Found

Teleflex Inc
Glance View

Market Cap
8.2B USD
Industry
Health Care
Economic Moat
None

In the world of medical technology, Teleflex Inc. emerges as a nuanced, multifaceted player, crafting a narrative not just of survival, but of steady growth through innovation and strategic vision. Founded in the allure of post-war optimism in 1943, Teleflex began its journey in the aerospace and marine industries. However, recognizing the steadily aging global population and increasing healthcare demands, the company pivoted towards the medical sector, a decision that has since defined its contemporary identity. Teleflex now thrives as a diversified global provider of medical technologies designed to improve health and the quality of people's lives. It specializes in critical care and surgical solutions, focusing its efforts on areas like vascular access, anesthesia, respiratory care, and urology, among others. Teleflex Inc. crafts its financial landscape through a robust combination of product innovation, strategic acquisitions, and a strong global footprint. Their revenue streams are primarily derived from selling medical devices and equipment to healthcare providers worldwide. A significant competitive edge lies in its ability to consistently introduce new products that address unmet clinical needs while enhancing patient safety and outcomes. This focus is evident in their Research and Development initiatives, which are integral to maintaining their market position. Moreover, by acquiring companies with complementary technologies and market reach, Teleflex continually broadens its portfolio, navigating the complex and evolving healthcare landscape with finesse and agility. Through these strategic maneuvers, the company ensures a steady flow of revenue that aligns with global healthcare trends and demands.

TFX Intrinsic Value
276.95 USD
Undervaluation 36%
Intrinsic Value
Price

See Also

What is Teleflex Inc's Operating Income?
Operating Income
539.8m USD

Based on the financial report for Sep 29, 2024, Teleflex Inc's Operating Income amounts to 539.8m USD.

What is Teleflex Inc's Operating Income growth rate?
Operating Income CAGR 10Y
6%

Over the last year, the Operating Income growth was -6%. The average annual Operating Income growth rates for Teleflex Inc have been 2% over the past three years , 4% over the past five years , and 6% over the past ten years .

Back to Top